Demographics |
Age |
|
|
|
|
<0.001 |
18–49 |
38,773 |
(11.0) |
12,457 |
(32.1) |
|
50–64 |
69,311 |
(19.7) |
26,582 |
(38.4) |
|
65–79 |
123,387 |
(35.1) |
46,069 |
(37.3) |
|
80+ |
120,064 |
(34.2) |
40,325 |
(33.6) |
|
Gender |
|
|
|
|
<0.001 |
Male |
147,910 |
(42.1) |
54,211 |
(36.7) |
|
Female |
203,616 |
(57.9) |
71,218 |
(35.0) |
|
Race |
|
|
|
|
<0.001 |
White |
231,184 |
(65.8) |
81,739 |
(35.4) |
|
Black |
55,712 |
(15.8) |
22,517 |
(40.4) |
|
Hispanic |
13,745 |
(3.9) |
4,742 |
(34.5) |
|
Other |
50,894 |
(14.5) |
16,435 |
(32.3) |
|
Primary diagnosis |
|
|
|
|
<0.001 |
Community-acquired pneumonia |
108,639 |
(30.9) |
33,098 |
(30.5) |
|
Septicemia |
11,576 |
(3.3) |
4,494 |
(38.8) |
|
Chronic obstructive pulmonary disease |
45,888 |
(13.1) |
15,152 |
(33.0) |
|
Respiratory failure |
13,015 |
(3.7) |
8,007 |
(61.5) |
|
Congestive heart failure |
85,222 |
(24.2) |
36,359 |
(42.7) |
|
Stroke |
49,557 |
(14.1) |
20,656 |
(41.7) |
|
Urinary tract infection |
37,638 |
(10.7) |
7,667 |
(20.4) |
|
Attending specialty |
|
|
|
|
<0.001 |
Internist |
190,284 |
(54.1) |
70,459 |
(37.0) |
|
GP/family medicine |
71,765 |
(20.4) |
19,118 |
(26.6) |
|
Cardiologist |
25,508 |
(7.3) |
10,467 |
(41.0) |
|
Pulmonologist |
21,009 |
(6.0) |
8,955 |
(42.6) |
|
Nephrology |
8,522 |
(2.4) |
2,521 |
(29.6) |
|
Other |
34,447 |
(9.8) |
13,913 |
(40.4) |
|
Insurance payor |
|
|
|
|
<0.001 |
Medicare traditional |
235,033 |
(66.9) |
82,534 |
(35.1) |
|
Medicare-managed care |
16,347 |
(4.7) |
6,477 |
(39.6) |
|
Medicaid |
23,120 |
(6.6) |
8,511 |
(36.8) |
|
Private |
61,505 |
(17.5) |
22,388 |
(36.4) |
|
Self-pay/uninsured/other |
15,530 |
(4.4) |
5,523 |
(35.6) |
|
Risk factors for VTE |
Admitted from skilled nursing facility |
4,460 |
(1.3) |
1,523 |
(34.1) |
0.03 |
Paralysis |
25,311 |
(7.2) |
10,770 |
(42.6) |
<0.001 |
Restraints |
4,759 |
(1.4) |
2,690 |
(56.5) |
<0.001 |
Decubitus ulcer |
10,591 |
(3.0) |
4,143 |
(39.1) |
<0.001 |
Cancer |
48,180 |
(13.7) |
16,527 |
(34.3) |
<0.001 |
Chemotherapy |
1,033 |
(0.3) |
358 |
(34.7) |
0.49 |
Prior venous thromboembolism |
5,553 |
(1.6) |
2,445 |
(44.0) |
<0.001 |
Pregnancy |
27 |
(0.0) |
7 |
(25.9) |
0.29 |
Estrogens |
5,368 |
(1.5) |
1,594 |
(29.7) |
<0.001 |
Estrogen modulators |
2,648 |
(0.8) |
818 |
(30.9) |
<0.001 |
Secondary diagnosis of atrial fibrillation |
57,192 |
(16.3) |
25,134 |
(43.9) |
<0.001 |
Prosthetic heart valve |
3,250 |
(0.9) |
1,145 |
(35.2) |
0.59 |
Congestive heart failure |
35,116 |
(10.0) |
15,673 |
(44.6) |
<0.001 |
Respiratory failure-secondary diagnosis |
24,760 |
(7.0) |
13,144 |
(53.1) |
<0.001 |
Inflammatory bowel disease |
1,149 |
(0.3) |
382 |
(33.2) |
0.08 |
Nephrotic syndrome |
794 |
(0.2) |
319 |
(40.2) |
0.008 |
Myeloproliferative disorder |
3,118 |
(0.9) |
1,063 |
(34.1) |
0.06 |
Paroxysmal nocturnal hemoglobinuria |
9 |
(0.0) |
3 |
(33.3) |
0.88 |
Obesity |
26,705 |
(7.6) |
12,169 |
(45.6) |
<0.001 |
Smoking |
47,139 |
(13.4) |
18,150 |
(38.5) |
<0.001 |
Varicose veins |
309 |
(0.1) |
98 |
(31.7) |
0.15 |
Central line |
10,662 |
(3.0) |
5,872 |
(55.1) |
<0.001 |
Inherited or acquired thrombophilia |
295 |
(0.1) |
127 |
(43.1) |
0.008 |
Diabetes mellitus |
110,717 |
(31.5) |
42,407 |
(38.3) |
<0.001 |
Mechanical ventilation |
18,808 |
(5.4) |
12,585 |
(66.9) |
<0.001 |
Computed risk of VTE |
|
|
|
|
<0.001 |
<0.5% |
278,807 |
(79.3) |
94,195 |
(33.8) |
|
0.5% to 1.0% |
49,587 |
(14.1) |
19,221 |
(38.8) |
|
>1.0% |
23,132 |
(6.6) |
12,013 |
(51.9) |
|
Hospital characteristics |
Region |
|
|
|
|
<0.001 |
South |
193,848 |
(55.1) |
68,258 |
(35.2) |
|
Midwest |
66,364 |
(18.9) |
25,744 |
(38.8) |
|
West |
38,175 |
(10.9) |
10,435 |
(27.3) |
|
Northeast |
53,148 |
(15.1) |
20,996 |
(39.5) |
|
Number of beds |
|
|
|
|
<0.001 |
0–200 |
61,287 |
(17.4) |
15,931 |
(26.0) |
|
201–300 |
57,205 |
(16.3) |
17,491 |
(30.6) |
|
301–500 |
126,695 |
(36.0) |
46,454 |
(36.7) |
|
>500 |
106,348 |
(30.3) |
45,557 |
(42.8) |
|
Teaching hospital |
117,949 |
(33.6) |
50,336 |
(42.7) |
<0.001 |
Rural hospital |
75,058 |
(21.4) |
21,174 |
(28.2) |
<0.001 |